relax regarding ce and website, page-11

'Blanket ramping statements that dismiss all risks are ignorant.'

Matt, who's been blanket ramping on HC re TIS? If anything TIS is one of the few threads were thoughtful discussions are had based upon known facts, positive, negative or neutral.

I don't see anyone making outlandish SP predictions or predicting massive revenue/profit forecasts in the ST.

No share purchased on the ASX today is without risks, the things you talk about are well known wrt TIS. CE mark approval is a risk, nothing is a gimme.

If CE mark is given this will be a significant milestone for the company and will ensure a company rerating.

I guess we will have to wait on how Vitrogo is rolled out, but from my understanding TIS will have significantly more revenue, control & focus of product launch with their arrangement with Quintiles than they would have had with just a roylaty payment from a major pharma with competing products to sell

Good luck with your endevours to buy back cheap if CE Mark approval is given, I trust you understand if I wish this does not eventuate.